Laparoscopic microwave coagulation therapy for hepatocellular carcinoma

Endoscopy

Volumn 32, Issue 8, 2000, Pages 591-597

  Seki, S ^a   Sakaguchi, H ^a   Kadoya, H ^a   Morikawa, H ^a   Habu, D ^a   Nishiguchi, S ^a   Shiomi, S ^a   Kitada, T ^a   Kuroki, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; LAPAROSCOPY; LIVER CELL CARCINOMA; LOCAL ANESTHESIA; MICROWAVE IRRADIATION; PNEUMOTHORAX; PRIORITY JOURNAL; ULTRASOUND;

AGED; CARCINOMA, HEPATOCELLULAR; ELECTRODES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LAPAROSCOPY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033909396     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9014     Document Type: Article

References (31)

1. Steiner PE. Cancer of the liver and cirrhosis in trans-Sahara Africa and the United States of America. Cancer 1960; 13: 1085-1066
2. Liaw YF, Chu CM, Lin DY, et al. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Med Virol 1984; 13: 385-391
3. Nishioka K, Watanabe J, Furuta S, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma. Cancer 1991; 67: 429-433
4. Arii S, Tanaka J, Yamazoe Y, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992; 69: 913-919
5. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-350
6. Kinoshita H, Hirohashi K, Kubo S, et al. Diagnosis and treatment for small hepatocellular carcinoma. Asian Med J 1993; 36: 51-54
7. Ebara M, Ohto M, Sugiura N, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: study of 95 patients. J Gastrol Hepatol 1990; 5: 616-626
8. Shina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160: 1023-1028
9. Yamada R, Sato M, Kawabata M, et al. Hepatic arterial embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401
10. Takayasu K, Wakao F, Moriyama N, et al. Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization. Am J Roentgenol 1993; 160: 301-306
11. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817-825
12. Ido K, Isoda N, Kawamoto C, et al. Laparoscopic microwave coagulation therapy for solitary hepatocellular carcinoma performed under laparoscopic ultrasonography. Gastrointest Endosc 1997; 45: 415-420
13. Tabuse K, Katsumi M, Kobayashi Y, et al. Microwave surgery: hepatectomy using microwave tissue coagulator. World J Surg 1985; 9: 136-143
14. Hamazoe R, Hirooka Y, Ohtani S, et al. Intraoperative microwave tissue coagulation as treatment for patients with non-resectable hepatocellular carcinoma. Cancer 1995; 75: 794-800
15. Itai Y, Ohtomo K, Kokubo T, et al. CT of hepatic masses: significant of prolonged and delayed enhancement. Am J Roentgenol 1986; 146: 729-733
16. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, et al. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (<1.5cm) malignant hepatic neoplasms. Am J Roentgenol 1995; 164: 879-884
17. Takayasu K, Furukawa H, Wakao F, et al. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. Am J Roentgenol 1995; 164: 885-890
18. Oliver JM III, Baron RL. Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology 1996; 201: 1-14
19. Kobayashi K, Sugimoto T, Makino T, et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 1985; 5: 1100-1105
20. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-494
21. Nagasue N, Yukaya H, Chang YC, et al. Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma. Surg Gynecol Obstet 1990; 171: 217-222
22. Ngao, T, Inoue S, Yoshimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211: 28-33
23. Tobe T, Kameda H, Okudaira M, et al. Summary of the data from a follow-up study by the Liver Cancer Study Group of Japan. In: Tobe T, Kameda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M (eds). Primary liver cancer in Japan. Tokyo: Springer, 1992: 31-37
24. Okamoto E, Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: report 12 [in Japanese with English abstract]. Acta Hepatol Jpn 1997; 38: 12-33
25. Eguchi A, Nakashima O, Okudaira S, et al. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 1992; 15: 843-848
26. Shibata M, Morizane T, Uchida T, et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C virus infection. Lancet 1998; 351: 1773-1777
27. Terasaki S, Kaneko S, Kobayashi K, et al. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998; 115: 1216-1222
28. Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25: 87-92
29. Ebara M, Kita K, Sugiura N, et al. Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. Radiology 1995; 195: 371-377
30. Nishiguchi S, Kuroki T, Nakatani S, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-1055
31. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334: 1561-1567